Managing side effects with CBD

Alex Capano, DNP, CRNP, FNP-BC

Alex Capano, DNP, CRNP, FNP-BC, is the chief science officer at Ecofibre Limited, a global biotech company focused on hemp-derived supplements, food, textiles, and medical devices. Most recently, Dr. Capano published a study on the possibility of using cannabinoids to reduce opioid use in chronic pain patients. Current projects include researching CBD's role in treating chemotherapy-induced neuropathic pain and agitation in dementia patients, as well as identifying industrial applications of hemp-derived cannabinoids. She is also a senior fellow at Thomas Jefferson University and a board certified family nurse practitioner.

Brooke Worster MD, FACP

Brooke Worster MD, FACP, is an associate professor of medicine in the Thomas Jefferson University and Sidney Kimmel Medical College and practices supportive medicine and cancer pain management as the medical director of the Neu Center for Supportive Medicine and Cancer Survivorship. She is active teaching faculty for the medical students, residents and fellows and serves as director for the master’s program in cannabis at the Institute of Emerging Health Professions at SKMC. Her research interests, for which she has earned grant support involve the use, impact, and perceptions of cannabis in pain management and other serious illnesses.